DRTECH Corporation (KOSDAQ:214680)
1,814.00
-95.00 (-4.98%)
Mar 9, 2026, 3:30 PM KST
DRTECH Revenue
DRTECH had revenue of 34.04B KRW in the quarter ending September 30, 2025, with 27.94% growth. This brings the company's revenue in the last twelve months to 120.30B, up 28.93% year-over-year. In the year 2024, DRTECH had annual revenue of 97.56B with 5.54% growth.
Revenue (ttm)
120.30B
Revenue Growth
+28.93%
P/S Ratio
1.26
Revenue / Employee
331.40M
Employees
363
Market Cap
151.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 97.56B | 5.12B | 5.54% |
| Dec 31, 2023 | 92.44B | 2.96B | 3.31% |
| Dec 31, 2022 | 89.48B | 19.20B | 27.33% |
| Dec 31, 2021 | 70.28B | 15.01B | 27.16% |
| Dec 31, 2020 | 55.27B | 7.42B | 15.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InBody Co.,Ltd | 226.62B |
| Osang Healthcare Co.,Ltd | 119.03B |
| Ray Co., Ltd. | 97.57B |
| Bio Plus | 96.80B |
| LabGenomics | 89.36B |
| T&R Biofab | 20.67B |
| HASS Corp. | 17.18B |
| Sugentech | 9.01B |